Home Frontmatter
Article Publicly Available

Frontmatter

Published/Copyright: November 30, 2022
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
NeuroImmune Pharmacology and Therapeutics
From the journal NeuroImmune Pharmacology and Therapeutics Volume 1 Issue 1

Published Online: 2022-11-30
Published in Print: 2022-03-25

©2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Introducing NeuroImmune Pharmacology and Therapeutics (NIPT), the official journal of the Society on NeuroImmune Pharmacology (SNIP)
  4. Letter to the Editor
  5. “The Galaxy Within” on the cover of NeuroImmune Pharmacology & Therapeutics
  6. Research Articles
  7. Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate
  8. Using IPA tools to characterize molecular pathways underlying the involvement of IRF7 in antiviral response to HIV
  9. Letter to the Editor
  10. Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infection
  11. Brief Reports
  12. Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
  13. The 26th Scientific Conference of the Society on NeuroImmune Pharmacology: College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, June 1-3, 2022
https://doi.org/10.1515/nipt-2022-frontmatter1

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Introducing NeuroImmune Pharmacology and Therapeutics (NIPT), the official journal of the Society on NeuroImmune Pharmacology (SNIP)
  4. Letter to the Editor
  5. “The Galaxy Within” on the cover of NeuroImmune Pharmacology & Therapeutics
  6. Research Articles
  7. Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate
  8. Using IPA tools to characterize molecular pathways underlying the involvement of IRF7 in antiviral response to HIV
  9. Letter to the Editor
  10. Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infection
  11. Brief Reports
  12. Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
  13. The 26th Scientific Conference of the Society on NeuroImmune Pharmacology: College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, June 1-3, 2022
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/nipt-2022-frontmatter1/html
Scroll to top button